>>Leadership

How To Fix A Guidant: Boston Scientific's Tobin Opens Playbook

01 Dec 2006

Boston Scientific CEO Jim Tobin, in a series of addresses, defends his company's decision to spend $27.3 billion on Guidant Inc., warts and all. Defying criticism of the deal, Tobin lays out how Boston Scientific management corrected Guidant's problems--and why the new company will thrive.

By Tom Salemi

Wall Street analysts and investors have been soundly slamming Boston Scientific Corp. over the past six months since the Natick,...